On January 25, 2024, at the Hotel in Nine in Samseong-dong, K-DOC unveiled its latest strategic directions and accomplishments during an influential business presentation.
This year, K-DOC has significantly reinforced its position by concentrating its efforts on Indonesia and the Middle East, thereby enhancing its readiness for global market entry. This strategic focus has robustly established K-DOC's footprint in the international medical arena.
As an organization pioneering overseas expansion within the medical sector, K-DOC has over the past three years made impactful strides in challenging the global medical market. This has been achieved through the provision of precise and secure medical information. Furthermore, in collaboration with GHKOL experts appointed by the Korea Health Industry Development Institute, K-DOC has been proactive in mobilizing medical personnel and spearheading international medical initiatives.
CEO Seung-kook Cho highlighted the competitive edge of Korean medicine in various domains, including cosmetic surgery, relative to services offered in developed countries. He articulated K-DOC’s commitment to globally promoting Korean medical technology and services, thereby leading the charge in the international medical market and heralding a new era of significant exploration.
K-DOC is diversifying its portfolio across several medical domains, including the facilitation of hospital overseas expansion, medical personnel matching, domestic medical consulting, and the exportation of medical devices, biopharmaceuticals, and products within the cosmetic industry.
Notably, this year, K-DOC aims to broaden its international endeavors, particularly in dermatology, cosmetic surgery, and dentistry, by forging strategic partnerships with leading hospitals in Indonesia and the Middle East. This initiative is geared towards promoting the excellence of Korean medical services on a global scale.
K-DOC is dedicated to supporting the secure international expansion and commercialization of Korean medicine through strategic alliances with foreign hospitals, medical consulting firms, and Korean medical associations. Additionally, K-DOC is committed to enhancing collaborations with reputable entities, evidenced by the signing of letters of intent (LOI) for supporting medical personnel's overseas ventures and fostering the medical industry's development in conjunction with the International Healthcare Division of the Korea Health Industry Development Institute.
Deputy Representative Byung-il Kang underscored the rapid growth and escalating global recognition of our country's medical market, expressing K-DOC’s vision to unlock boundless opportunities through the international dissemination of Korean medicine.
The business presentation witnessed a significant turnout, with many attendees offering their encouragement and support. We extend our deepest gratitude to all participants and invite continued interest and backing for K-DOC's ongoing development and endeavors.
On January 25, 2024, at the Hotel in Nine in Samseong-dong, K-DOC unveiled its latest strategic directions and accomplishments during an influential business presentation.
This year, K-DOC has significantly reinforced its position by concentrating its efforts on Indonesia and the Middle East, thereby enhancing its readiness for global market entry. This strategic focus has robustly established K-DOC's footprint in the international medical arena.
As an organization pioneering overseas expansion within the medical sector, K-DOC has over the past three years made impactful strides in challenging the global medical market. This has been achieved through the provision of precise and secure medical information. Furthermore, in collaboration with GHKOL experts appointed by the Korea Health Industry Development Institute, K-DOC has been proactive in mobilizing medical personnel and spearheading international medical initiatives.
CEO Seung-kook Cho highlighted the competitive edge of Korean medicine in various domains, including cosmetic surgery, relative to services offered in developed countries. He articulated K-DOC’s commitment to globally promoting Korean medical technology and services, thereby leading the charge in the international medical market and heralding a new era of significant exploration.
K-DOC is diversifying its portfolio across several medical domains, including the facilitation of hospital overseas expansion, medical personnel matching, domestic medical consulting, and the exportation of medical devices, biopharmaceuticals, and products within the cosmetic industry.
Notably, this year, K-DOC aims to broaden its international endeavors, particularly in dermatology, cosmetic surgery, and dentistry, by forging strategic partnerships with leading hospitals in Indonesia and the Middle East. This initiative is geared towards promoting the excellence of Korean medical services on a global scale.
K-DOC is dedicated to supporting the secure international expansion and commercialization of Korean medicine through strategic alliances with foreign hospitals, medical consulting firms, and Korean medical associations. Additionally, K-DOC is committed to enhancing collaborations with reputable entities, evidenced by the signing of letters of intent (LOI) for supporting medical personnel's overseas ventures and fostering the medical industry's development in conjunction with the International Healthcare Division of the Korea Health Industry Development Institute.
Deputy Representative Byung-il Kang underscored the rapid growth and escalating global recognition of our country's medical market, expressing K-DOC’s vision to unlock boundless opportunities through the international dissemination of Korean medicine.
The business presentation witnessed a significant turnout, with many attendees offering their encouragement and support. We extend our deepest gratitude to all participants and invite continued interest and backing for K-DOC's ongoing development and endeavors.